Nanostructures of metal oxide semiconductors play significant roles in a variety of areas, such as biotherapy, pollutant treatment and energy storage and conversion. The molybdenum oxide (MoO 3−x ) nanostructures have shown promising applications especially when used as photothermal treatment agents due to their relatively low cost, facile synthesis and low toxicity. However, the design and synthesis of efficient MoO 3−x nanomaterials with tunable phases and morphologies for theragnosis of tumors remains a challenge. In this work, hydrophilic MoO 3−x with controlled structures and phases was synthesized by a simple one-step hydrothermal process. The as-obtained MoO 2 nanoclusters showed a desirable size of ∼40 nm in diameter exhibiting unique properties as a theragnosis nanoplatform: (1) strong near-infrared absorption, which is due to oxygen vacancies of the nanoclusters, as proved by photoluminescence spectroscopy and X-ray photoelectron spectroscopy; (2) excellent photothermal performance with a photothermal conversion efficiency of up to 62.1%; and (3) the image response of X-ray computed tomography (CT) and infrared thermal imaging for simultaneous diagnosis of tumors. This study provided the facile synthetic strategy for controllable metal oxide semiconductors and promoted the development of metal oxides for theragnosis therapy of cancers.
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Photothermal therapy (PTT) for cancer ablation has attracted great research interest recently as an alternative to traditional cancer treatments. The MoO 3−x nanostructures have shown promising applications especially when used as PTT agents due to their relatively low cost, mild synthesis, excellent photothermal performance and low toxicity. 12, 13, 17 Remarkable achievements have been made for MoO 3−x around biomedical applications, especially as PTT agents, but there remain prominent challenges such as materials synthesis procedures, size-controlled MoO 3−x nanostructures and improvement of photothermal performance. 13, 18 Facile fabrication of MoO 3−x nanostructures was first realized by Song et al. 17 They showed that complicated post treatments of hydrophobic and less biocompatible oleylamine molecules coated nanomaterials could be avoided. However, the sizes of the nanostructures are relatively large and not suitable for bioapplications. It is well-known that often particle sizes larger than 100 nm will accumulate in the vital organs, such as livers. 19 The hysteretic clearance of those materials from the organisms could cause serious toxicity and lead to long-term inflammatory response. Quantum dots of MoO 3−x were synthesized for use as photoacoustic imaging guided photothermal/photodynamic cancer treatment. However, quantum dots suffer from the disadvantage of shorter blood circulation time which is not in favor of the uptake of PTT agents by tumors. 12 All-in-One theragnosis nanomaterials exhibiting excellent photothermal performances as well as the ability to diagnose cancers has become a research hotspots. Molybdenum has strong X-ray attenuation which can be used in diagnostic applications such as X-ray computed tomography (CT) imaging. 20 To the best of our knowledge, there is no report related to one-step synthesis of MoO 3−x with suitable nanostructures for use as an effective CT and infrared thermal imaging guided PTT agents.
Herein, we rationally designed a facile one-step hydrothermal method to synthesize MoO 3−x materials with varied nanostructures (nanotubes, nanoflakes, nanoflowers and nanoclusters) by simply changing the temperature and reagents used in the reactions. The as-obtained self-assembled MoO 2 nanoclusters can be used as the highly efficient CT and infrared thermal imaging guided PTT agents for cancer treatment in vivo.
MoO 3−x nanostructures with tunable phases and morphologies were synthesized from one-step hydrothermal process by using ammonium molybdate tetrahydrate as the Mo source and polyethylene glycol 400 (PEG-400) as the reductant and the hydrophilic coating layer. The morphologies of the as-obtained materials were firstly investigated by scanning electron microscopy (SEM). By controlling the temperature of the reactions at 90, 120, 150 or 180°C, different morphologies of MoO 3−x nanostructures i.e. nanocubes, nanoflakes, nanoflowers and nanoclusters could be obtained. At lower temperatures, the products are relatively large with the size of hundreds of nanometers to several micrometers ( 7 The major difference between the O 1s is at 532.6 eV, assigned to -OH in carbon chains from the hydrophilic modification by PEG-400 of MoO 2 nanoclusters. 22 In addition, the obvious peaks corresponded to oxygen vacancies in the matrix of metal oxides can be fitted to MoO 2 nanostructures, this was also proved by photoluminescence spectrum (Fig. S7 †) , which is the primary reason for LSPR phenomenon of transitional metal oxide materials. It is well known that the surface chemistry of nanomaterials is very important for their biological application. Polyethylene glycol (PEG) is extensively applied to functionalize biomaterials to improve their dispersity and biocompatibility. 23, 24 As a result, the PEG coated MoO 2 nanoclusters are hydrophilic without any modification, and they can well be dispersed in water, saline, and RPMI-1640 culture medium without any noticeable agglomeration over a week (Fig. S8 †) due to the small size and PEG coating. Then, UV-vis absorbance spectra were recorded for MoO 2 nanoclusters and MoO 3 nanorods. Shown in Fig. 3a , compared with MoO 3 , MoO 2 nanoclusters presented stronger adsorption from 600-1000 nm with a peak maximum at 800 nm. Based on this light absorption character, an 808 nm laser was chosen to study the photothermal performance of MoO 2 nanoclusters. Under a continuous irradiation laser with a power density of 0.5 W cm −2 , the temperature of different concentration (0-500 ppm) of MoO 2 nanoclusters aqueous solutions was recorded. As shown in Fig. 3b and Fig. S9 , † the nanoclusters exhibited concentration-dependent photothermal effects, as a control, the temperature of pure water showed little change (increase of 0.8°C). The temperature increases of the MoO 2 nanoclusters aqueous dispersion change from 13.3 to 38.6°C. We then measured the photothermal conversion efficiency of MoO 2 nanoclusters by a modified method similar to the reports on Cu 7.2 S 4 nanocrystals. 25 According to the obtained date shown in Fig. 3b 28 The high photothermal conversion efficiency should be attributed to the strong NIR absorption resulted from the oxygen-deficiency-induced small polarons in MoO 2 nanoclusters and effective nonradiative electron relaxation dynamics, 29 as well as the special structure of MoO 2 nanoclusters which can serve as excellent laser-cavity mirrors of a 808 nm laser. 30 What's more, the as-prepared MoO 2 nanoclusters showed great NIR photostability without any significant decrease in the optical absorbance even upon a long time irradiation by a 2 W, 808 nm laser, whereas Au nanorods displayed notable changes in their optical properties (Fig. S11 †) . These results indicated that MoO 2 nanoclusters can be a promising 808 nm-laser-driven photothermal agent. Prior to realizing the PTT in vivo, we evaluated the photothermal cytotoxicity of MoO 2 nanoclusters with and without laser irradiation on TC71 cells by CCK8 assay. These MoO 2 nanoclusters appeared to have low toxicity without NIR light irradiation. The cell viability was about 80% even at a high concentration up to 1000 ppm (Fig. S12a †) . However, when simultaneously treatments with MoO 2 nanoclusters and 808 nm laser illumination (0.5 W cm −2 , 5 min), the cell viabilities significantly decreased as the concentration increased (Fig. S12b †) . The in vivo therapeutic efficacy of the MoO 2 nanoclusters (250 ppm)-induced photothermal therapy cancer treatment using an 808 nm laser (0.5 W cm The mice from group (a) and (b) as a control were not irradiated, while the mice from group (c) and (d) were simultaneously exposed to an 808 nm laser. During the laser treatment, full-body infrared thermal images were captured using an IR camera. As shown in the inset of Fig. 3c , it can be clearly noticed that the region 11 framed area injected with the MoO 2 nanoclusters generates a greater temperature increase under irradiation, while, as a control, limited temperature change was detected in the region 12 framed area. The temperature of the irradiated area was also recorded as a function of the irradiation time (Fig. 3c) . For the mouse injected with saline solution (region 12), the surface temperature of the tumor increased by less than 2°C. However, in the case of the MoO 2 nanoclusters-injected mouse (region 11), the tumor surface temperature increased rapidly and reached up to 53.6°C after 50 s, and then change to plateau at about 53.5 ± 0.7°C. These results reveal a rapid elevation of temperature of the in vivo tumor, which suggests that the MoO 2 nanoclusters in vivo have an excellent photothermal effect. To further evaluate photothermal ablation of cancer cells in vivo, the histological examination of tumors was performed a day after treatments by means of microscopic imaging (Fig. 3d) . As expected, significant cancer cell damage was noticed only in the tumor with both MoO 2 nanostructures injection and laser irradiation, but not in the three control groups. The experimental group shows severe cellular damage ( pyknosis, karyorrhexis and karyolysis). In the control groups, there are no obvious differences regarding the cells' size and shape, nuclear modifications, or necrosis. These facts suggest that in vivo cancer cells can be efficiently destroyed by the excellent photothermal effect of MoO 2 nanoclusters. Fig. 4a presents the CT image of an aqueous dispersion of the MoO 2 nanoclusters at different concentrations. We can clearly observe that CT signal intensity is enhanced with an increase in the concentrations. Meanwhile, the Hounsfield Units (HU) values increased linearly with the concentration for the MoO 2 nanostructures as shown in Fig. 4b . The slope of the HU value was about 15.1 HU L g −1 . We then studied in vivo CT imaging using the MoO 2 nanostructures as a CT contrast agent. These MoO 2 nanoclusters dispersed in a PBS solution were intratumorally injected into a tumor-bearing mouse. Fig. 4c shows the in vivo tumor CT images before and after intratumoral injection with the MoO 2 solution (100 μL, 10 000 ppm). The corresponding injection site exhibited a brighter contrast than other soft tissues. Meanwhile, the mean CT value of the injection sites is much higher than the value of the soft tissues. The CT value of the tumor area post-injection was significantly higher than that of the tumor area before injection (a mean value: 147 versus 15). Therefore, these results obviously indicated that the MoO 2 nanostructures can be a promising CT contrast agent in vivo.
In conclusion, by controlling the reductants and reaction temperature in the hydrothermal synthesis, various phases and morphologies of MoO 3−x nanostructures can be synthesized. MoO 2 nanoclusters obtained at 180°C have a size of 40 nm and can be used for bioapplications. Due to the intense NIR absorption and high photothermal conversion of 62.1%, MoO 2 nanoclusters were used as the PTT agents to kill cancer cells in vitro and in vivo efficiently under the irradiation of an 808 nm laser at a safe intensity of 0.5 W cm −2 . In addition, the CT response are reported for the first time of this kind of metal oxides. Therefore, MoO 2 nanoclusters are promising candidates for theragnosis therapy of cancers. 
